[Combined local and vaginal therapy in Buruli ulcer].
Milánkovits
Márton
M
D017088:AIDS-Related Opportunistic Infections / Q000628:therapy; D000293:Adolescent; D017677:Age Distribution; D000368:Aged; D000583:Amikacin / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D054312:Buruli Ulcer / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery / Q000628:therapy*; D002648:Child; D003131:Combined Modality Therapy; D003646:Debridement; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008795:Metronidazole / Q000627:therapeutic use; D019911:Mycobacterium ulcerans / Q000187:drug effects; D010019:Osteomyelitis / Q000382:microbiology*; D012293:Rifampin / Q000627:therapeutic use; D013307:Streptomycin / Q000627:therapeutic use
D000890:Anti-Infective Agents; D008795:Metronidazole; D000583:Amikacin; D012293:Rifampin; D013307:Streptomycin